PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 7th, 2022 • Statera Biopharma, Inc. • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • February 7th, 2022 • Statera Biopharma, Inc. • Pharmaceutical preparations
This COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 6, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 6, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Statera Biopharma, Inc., a Delaware corporation (the “Company”), up to 2,000,000 shares (subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 7th, 2022 • Statera Biopharma, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 6, 2022 between Statera Biopharma, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
